URI Drug Study Produces ‘Promising Therapy’ for Alcohol Abuse
University of Rhode IslandResearchers are testing the safety and efficacy of a drug originally developed by Pfizer to treat obesity and diabetes that blocks gherlin, known as the hunger hormone. In those with alcohol use disorder, higher concentrations of ghrelin are associated with higher alcohol craving and consumption. The researchers believe that an oral medication that blocks ghrelin may help stave off cravings for alcohol.